Paraneoplastic dermatomyositis and prostate cancer: Myopathy regression under cancer-directed therapy

Mafalda Miranda Baleiras1, Luís Maduro1, Carolina Vasques1

  • 1Hospital São Francisco Xavier, Centro Hospitalar Lisboa Ocidental, Portugal.

Dermatology Reports
|December 9, 2021
PubMed

Insights

Dermatomyositis, a rare inflammatory disorder, can be a paraneoplastic syndrome associated with cancer. Treating the underlying malignancy improved symptoms, and their recurrence signaled tumor progression in a prostate cancer patient.

Area of Science:

  • Rheumatology
  • Oncology
  • Dermatology

Background:

  • Dermatomyositis (DM) is a rare idiopathic inflammatory myopathy with characteristic skin and muscle manifestations.
  • DM can present as a paraneoplastic syndrome, indicating an underlying neoplasm.
  • Prostate cancer is a significant global malignancy in men.

Purpose of the Study:

  • To report a case of prostate adenocarcinoma presenting with dermatomyositis as a paraneoplastic syndrome.
  • To highlight the relationship between dermatomyositis and underlying malignancy.
  • To emphasize the potential of dermatomyositis symptoms as an early warning for malignancy recurrence.

Main Methods:

  • Case report of a 65-year-old male patient.
  • Clinical presentation included dysphagia, muscle weakness, and facial rash.
  • Diagnosis of prostate adenocarcinoma and dermatomyositis.

Main Results:

  • The patient's dermatomyositis symptoms initially improved with prostate cancer treatment.
  • Dermatomyositis symptoms recurred and worsened as the prostate tumor progressed.
  • This case illustrates the paraneoplastic association between prostate cancer and dermatomyositis.

Conclusions:

  • Dermatomyositis is a rare systemic disorder with a known association with malignancy.
  • Treatment targeting the underlying malignancy can lead to improvement in DM manifestations.
  • Recurrence of DM symptoms may serve as an indicator of malignancy relapse, necessitating vigilant monitoring.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K